This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
FDA Conducting Safety Review of Certain Prostate Cancer Drugs
Studies Link GnRH Agonists to Increased Risk for Diabetes, Cardiovascular Disease
By News Staff
The FDA said in a May 3 news release that its review is ongoing, and the agency has not reached any conclusions about whether the products increase the risk of developing diabetes or cardiovascular disease. However, according to a May 3 safety communication from the agency, data from six studies that compared outcomes in patients undergoing ADT with those in patients not undergoing the treatment indicate a small increased risk for these conditions.
The FDA offered the following advice for physicians and patients:
- physicians should carefully weigh the benefits and risks of prescribing GnRH agonists when determining treatment;
- patients receiving GnRH agonists should be monitored for development of diabetes and cardiovascular disease;
- physicians should manage patients' cardiovascular risk factors, such as smoking and increases in blood pressure, cholesterol, blood sugar, and weight, according to current clinical practice; and
- patients should not stop their treatment with GnRH agonists unless told to do so by their physicians.
GnRH agonists also are used in children to treat central precocious puberty, as well as in women for the management of endometriosis, preoperative improvement of anemia caused by uterine fibroids and palliative treatment of advanced breast cancer. However, the FDA said there are no known comparable epidemiologic studies evaluating the risk of diabetes and cardiovascular disease in children or women.
FDA Safety Alert: "GnRH Agonists: Safety Review of Drug Class Used to Treat Prostate Cancer"
(May 3, 2010)
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients
